CAS: 1476074-39-1
| Marchio | Dati del prodotto | Purezza | Fascia di prezzo | Consegna prevista |
|---|---|---|---|---|
 | 4-Quinolinecarboxamide, N-methyl-8-[(1S)-1-methyl-2-[(2'-methyl[4,5'-bipyrimidin]-6-yl-4',6'-d2)amino]ethyl]- REF: IN-DA001F09CAS: 1476074-39-1 | % | Prezzo su richiesta | Lun 03 Mar 25 |
 | VX-984 REF: TM-T11067CAS: 1476074-39-1 | 97.65% | 104,00 €~3.597,00 € | Lun 02 Giu 25 |
![4-Quinolinecarboxamide, N-methyl-8-[(1S)-1-methyl-2-[(2'-methyl[4,5'-bipyrimidin]-6-yl-4',6'-d2)am…](https://static.cymitquimica.com/products/IN/thumb/DA001F09.jpg)
4-Quinolinecarboxamide, N-methyl-8-[(1S)-1-methyl-2-[(2'-methyl[4,5'-bipyrimidin]-6-yl-4',6'-d2)amino]ethyl]-
CAS:1476074-39-1
Formula:
C23H21D2N7O
Purezza:
%
Peso molecolare:
415.4873
Ref: IN-DA001F09
| 5mg | 180,00 € | ||
| 10mg | 302,00 € | ||
| 25mg | 567,00 € | ||
| 50mg | Prezzo su richiesta |
Consegna stimata in Stati Uniti, il Lunedì 03 Marzo 2025
VX-984
CAS:1476074-39-1
VX-984 (M9831) is an oral DNA-PK inhibitor, crossing the blood-brain barrier, targeting GBM and NSC-LC.
Formula:
C23H21D2N7O
Purezza:
97.65%
Colore e forma:
Solid
Peso molecolare:
415.49
Ref: TM-T11067
| 1mg | 104,00 € | ||
| 5mg | 259,00 € | ||
| 10mg | 383,00 € | ||
| 25mg | 605,00 € | ||
| 50mg | 815,00 € | ||
| 100mg | 1.093,00 € | ||
| 200mg | 1.473,00 € | ||
| 1mL*10mM (DMSO) | 279,00 € |
Consegna stimata in Stati Uniti, il Lunedì 02 Giugno 2025
